Lynx, a fintech platform simplifying healthcare payments and administration, announced the close of an oversubscribed $27 million Series A funding round, bringing its total funding to over $44 million since its inception in 2022.
The round was led by Flare Capital Partners, with participation from CVS Health Ventures, McKesson Ventures, and existing investors .406 Ventures, Obvious Ventures, and Frist Cressey Ventures.
Lynx plans to use the funding to scale operations and accelerate its growth in the strategic areas.
Matthew Renfro, Co-Founder & CEO of Lynx, said: “This recent funding will fuel our expansion across all channels, empowering us to continue driving innovation and delivering exceptional value to health plans, financial institutions, administrators, and members alike.”